Ciclopirox Inhibition of eIF5A Hypusination Attenuates Fibroblast Activation and Cardiac Fibrosis
Cardiac fibrosis is a primary contributor to heart failure (HF), and is considered to be a targetable process for HF therapy. Cardiac fibroblast (CF) activation accompanied by excessive extracellular matrix (ECM) production is central to the initiation and maintenance of fibrotic scarring in cardiac...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI AG
2023-01-01
|
| シリーズ: | Journal of Cardiovascular Development and Disease |
| 主題: | |
| オンライン･アクセス: | https://www.mdpi.com/2308-3425/10/2/52 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|